Aortic Root Surgery The Biological Solution /
The surgical treatment of the aortic valve and root disease, organic and ischemic mitral regurgitation, and endocarditis has made great strides. Still, there is the well-known dilemma: on the one hand the need for anticoagulation in patients with mechanical valves that otherwise guarantee long-term...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | , , |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Heidelberg :
Steinkopff,
2010.
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Imaging of the aortic root
- Perioperative imaging for assessing aortic and mitral valve diseases and surgical procedures
- Innovations in aortic valve surgery
- The aortic root
- Percutaneous transluminal aortic valve replacement: The CoreValve prosthesis
- Transapical aortic valve implantation — A truly minimally invasive option for high-risk patients
- From minimally invasive to percutaneous aortic valve replacement
- Sutureless equine aortic valve replacement
- The Ross operation: Aortic valve and root replacement with pulmonary autograft
- Pulmonary autograft or aortic allograft for surgical treatment of active infective aortic valve endocarditis: a review of the literature
- The Ross operation: two decades of clinical experience
- Aortic valve repair and valve sparing root procedures
- The bicuspid aortic valve
- From dynamic anatomy to conservative aortic valve surgery: the tale of the ring
- Yacoub/David techniques for aortic root operation: success and failures
- Aortic annuloplasty
- Correction of aortic valve incompetence combined with ascending aortic aneurysm by relocation of the aortic valve plane through a short-length aortic graft replacement
- Using BioGlue to achieve hemostasis in aortic root surgery
- Endocarditis
- Challenges in the surgical management of infective endocarditis
- Clinical results of the Shelhigh® stentless bioprosthesis in patients with active infective endocarditis:
- Double valve endocarditis and evolving paraannular abscess formation
- Aortic root abscess: reconstruction of the left ventricular outflow tract and allograft aortic valve and root replacement
- Implantation techniques of freehand subcoronary aortic valve and root replacement with a cryopreserved allograft for aortic root abscess
- Surgery for atrial fibrillation
- Cryoablation for the treatment of atrial fibrillation in patients undergoing minimally invasive mitral valve surgery
- Minimally invasive endoscopic ablation on the beating heart in patients with lone atrial fibrillation
- Hemodynamic evaluation of the bioprosthetic aortic valves
- Evaluation of bioprosthetic valve performance as a function of geometric orifice area and space efficiency— A reliable alternative to effective orifice area
- Long-term results of biological valves
- Stented and stentless aortic bioprostheses: competitive or complimentary?
- Edwards Prima Plus Stentless Bioprosthesis: Long-term clinical and hemodynamic results
- The Cryo-Life O’Brien stentless valve: 1991–2008
- Medtronic stentless Freestyle® porcine aortic valve replacement
- The ATS 3f Aortic Bioprosthesis
- The Vascutek Elan stentless porcine prosthesis — The Glasgow experience
- Sorin pericardial valves
- The changing role of pericardial tissue in biological valve surgery: 22 years’ experience with the Sorin Mitroflow stented pericardial valve
- 20 years’ durability of Carpentier-Edwards Perimount stented pericardial aortic valve
- Twenty-year experience with the St. Jude Medical Biocor bioprosthesis in the aortic position
- 20-Year durability of bioprostheses in the aortic position
- Clinical results including hemodynamic performance of the Medtronic Mosaic porcine bioprosthesis up to ten years
- Aortic root replacement with the BioValsalva prosthesis
- Valve replacement in renal dialysis patients: bioprostheses versus mechanical prostheses
- Replacement of bioprostheses after structural valve deterioration
- Predictors of patient’s outcome
- Predicted outcomes after aortic valve replacement in octogenarians with aortic stenosis
- Predicted patient outcome after bioprosthetic AVR and the Ross operation
- Anticoagulation
- Anticoagulation and self-management of INR: mid-term results
- Tissue engineering
- Biomatrix-polymer hybrid material for heart valve tissue engineering
- Standards for the in vitro fabrication of heart valves using human umbilical cord cells
- Tissue engineering with a decellularized valve matrix
- Regularatory issues on tissue valves
- Human tissues for cardiovascular surgery: regulatory requirements
- Concluding remarks
- Concluding remarks
- Atlas of biological valves
- Atlas of biological valves.
